V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290005256 | 290003837 | null | 55.1 | null | null | 2014-10-30 | Bevacizumab + Cape + Oxali 21day | N | Y | 290022657 | CETUXIMAB + RT |
| 290005257 | 290003838 | 1.76 | 79 | Adjuvant (A) | null | 2013-10-31 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290022661 | CAPECITABINE + RT |
| 290005258 | 290003839 | 1.92 | 65 | Palliative (P) | 2016-08-01 | 2016-08-19 | Capecitabine | 02 | N | 290022662 | CARBOPLATIN + PEMETREXED |
| 290005259 | 290003840 | 1.7 | 66.4 | Palliative (P) | 2012-10-30 | 2014-01-29 | CISPLATIN + GEMCITABINE | 02 | N | 290022664 | CVD |
| 290005260 | 290003841 | 1.6 | 53.2 | Palliative (P) | 2013-11-12 | 2013-11-23 | EOX | N | N | 290022666 | CETUXIMAB + CISPLATIN + FU |
| 290005261 | 290003842 | 1.66 | 70.4 | Curative (C) | 2015-03-31 | 2015-04-12 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290022667 | CISPLATIN + VINORELBINE |
| 290005262 | 290003843 | 1.64 | null | Neo-adjuvant (N) | 2014-11-26 | 2014-11-27 | Fluouracil continuous infusion | N | Y | 290022670 | CETUXIMAB + CISPLATIN + FU |
| 290005263 | 290003844 | 1.72 | 65.6 | Palliative (P) | null | 2016-11-28 | LU-177 | null | null | 290022673 | IPILIMUMAB |
| 290005264 | 290003845 | 1.61 | 53.5 | Palliative (P) | 2016-02-22 | 2016-03-13 | Capecitabine 35days + RT | 02 | N | 290022674 | CARBOPLATIN + RT |
| 290005265 | 290003846 | 1.62 | 42.6 | null | 2015-12-08 | 2015-12-22 | Fluorouracil 96hr infusion+R(4g/m2) | 02 | null | 290022676 | CAPECITABINE + RT |
| 290005266 | 290003846 | null | 65 | Neo-adjuvant (N) | 2017-02-19 | 2017-03-12 | ECX | N | N | 290022676 | CISPLATIN + FLUOROURACIL |
| 290005267 | 290003847 | 1.75 | 48 | Disease modification (D) | 2018-07-20 | 2018-08-09 | Capecitabine | N | N | 290022679 | CAPECITABINE + RT |
| 290005268 | 290003848 | 1.58 | 88 | Palliative (P) | 2016-11-22 | 2016-11-22 | Carboplatin + Paclitaxel (3 weekly) | 01 | N | 290022680 | OCTREOTIDE |
| 290005269 | 290003849 | 1.57 | 91 | Curative (C) | 2017-03-15 | 2017-03-26 | Capecitabine + Cisplatin | 02 | N | 290022684 | PEMBROLIZUMAB |
| 290005270 | 290003850 | null | null | Palliative (P) | 2019-03-09 | 2019-03-12 | Carbo F | N | N | 290022686 | IPILIMUMAB |
| 290005271 | 290003851 | null | null | Palliative (P) | 2017-09-27 | 2017-09-27 | Cetuximab + Irinotecan (Cycle 1) | N | N | 290022687 | CARBO + FLUOROURACIL |
| 290005272 | 290003852 | 1.51 | 47 | Disease modification (D) | 2018-01-05 | 2018-01-26 | Carboplatin 21day + Paclitaxel 7day | N | N | 290022688 | CISPLATIN + ETOPOSIDE |
| 290005273 | 290003852 | null | 80 | Curative (C) | 2017-03-17 | 2017-04-12 | R Chlorambucil | N | Y | 290022688 | FLUOROURACIL |
| 290005274 | 290003853 | 1.65 | 0 | Palliative (P) | 2014-06-05 | 2014-06-05 | LANREOTIDE | 02 | N | 290022692 | CISPLATIN + GEMCITABINE |
| 290005275 | 290003853 | 1.82 | 68.7 | Palliative (P) | 2018-01-01 | 2018-01-01 | FCarboSt | 02 | N | 290022692 | IVADO |
| 290005276 | 290003854 | 0 | 53.2 | Palliative (P) | 2018-01-11 | 2018-01-12 | BALLAD Trial | 02 | N | 290022696 | BENDAMUSTINE + RITUXIMAB |
| 290005277 | 290003855 | 1.78 | 72 | Curative (C) | 2017-06-15 | 2017-07-15 | LANREOTIDE | N | N | 290022697 | CARBOPLATIN |
| 290005278 | 290003855 | 1.84 | 76 | Palliative (P) | 2014-11-24 | 2014-11-24 | Carboplatin + Pemetrexed | 02 | N | 290022697 | CETUXIMAB + RT |
| 290005279 | 290003856 | 0 | 52.4 | null | null | 2019-03-27 | EOX | N | N | 290022701 | CAPECITABINE + CARBOPLATIN |
| 290005280 | 290003857 | 1.61 | 55 | Palliative (P) | 2018-04-07 | 2018-04-16 | OCTREOTIDE | 02 | N | 290022706 | FLUOROURACIL |
| 290005281 | 290003858 | null | null | Curative (C) | 2016-04-17 | 2016-04-28 | DE-ESCALATE TRIAL | N | N | 290022708 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005282 | 290003859 | 1.84 | null | Curative (C) | 2016-03-23 | 2016-03-23 | Irinotecan + Modified De Gramont | N | Y | 290022710 | CAPECITABINE + GEMCITABINE |
| 290005283 | 290003859 | 1.7 | 64.4 | Palliative (P) | 2017-09-23 | 2017-09-23 | EOX | N | N | 290022710 | CARBOPLATIN + RT |
| 290005284 | 290003860 | 1.78 | 61.45 | Palliative (P) | 2015-03-13 | 2015-03-29 | CISPLATIN + FLUOROURACIL | N | N | 290022712 | CAPECITABINE |
| 290005285 | 290003861 | 1.78 | null | Neo-adjuvant (N) | 2015-09-19 | 2015-09-28 | Cisplatin + Docetaxel +Fluorouracil | 2 | Y | 290022718 | CETUXIMAB + RT |
| 290005286 | 290003862 | 1.75 | 113 | Curative (C) | null | 2016-03-28 | Cetuximab + CISPLATIN + FLUOROURACIL | N | null | 290022719 | IRINOTECAN + MDG |
| 290005287 | 290003862 | 1.6 | 46.2 | Curative (C) | 2015-11-11 | 2015-11-17 | Capecitabine 35days + RT | N | N | 290022719 | LANREOTIDE |
| 290005288 | 290003863 | null | 65.5 | Disease modification (D) | 2014-04-14 | 2014-05-04 | LANREOTIDE | N | N | 290022722 | LANREOTIDE |
| 290005289 | 290006648 | null | null | Disease modification (D) | 2015-09-05 | 2015-10-18 | IPILIMUMAB + NIVOLUMAB | N | N | 290022726 | PLATO TRIAL |
| 290005290 | 290003864 | 1.76 | 56 | Curative (C) | 2015-10-14 | 2015-11-03 | LANREOTIDE | N | N | 290022728 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005291 | 290003865 | 1.72 | 61.7 | Neo-adjuvant (N) | null | 2013-12-19 | CAP + RT | N | N | 290022729 | CISPLATIN + ETOPOSIDE |
| 290005292 | 290003865 | 1.6 | 55 | null | 2017-08-02 | 2017-08-14 | Carboplatin + Pemetrexed | N | N | 290022729 | OCTREOTIDE |
| 290005293 | 290003865 | null | 61.5 | null | 2014-08-09 | 2014-08-09 | Trial Unspecified | 02 | N | 290022729 | EOX |
| 290005294 | 290003865 | null | null | Neo-adjuvant (N) | 2015-08-27 | 2015-09-08 | Irinotecan + Modified De Gramont | 2 | Y | 290022729 | OCTREOTIDE |
| 290005295 | 290003866 | 1.84 | 0 | null | 2016-06-17 | 2016-06-17 | Rituximab | 02 | null | 290022733 | CHOP R |
| 290005296 | 290003866 | 1.7 | 33.5 | Disease modification (D) | 2018-02-05 | 2018-02-05 | Capecitabine 35days + RT | 02 | N | 290022733 | LANREOTIDE |
| 290005297 | 290007797 | 1.72 | 96.8 | Curative (C) | 2013-02-10 | 2013-02-28 | Cisplatin +Fluorouracil (2 wk) | 02 | N | 290022737 | CAPECITABINE |
| 290005298 | 290007797 | null | 37 | Neo-adjuvant (N) | 2017-03-09 | 2017-04-03 | CHOP R - 21 days | N | Y | 290022737 | OCTREOTIDE |
| 290005299 | 290008379 | null | null | Neo-adjuvant (N) | 2013-01-21 | 2013-02-12 | Cisplatin + Docetaxel +Fluorouracil | null | N | 290022739 | LANREOTIDE |
| 290005300 | 290008379 | 1.6 | 77 | Palliative (P) | 2014-11-11 | 2014-11-13 | Fluorouracil 96hr infusion+R(4g/m2) | 2 | N | 290022739 | CARBOPLATIN |
| 290005301 | 290003867 | 1.64 | 77 | Palliative (P) | 2014-11-25 | 2014-11-25 | ECX | 02 | N | 290022744 | CARBOPLATIN + ETOPOSIDE |
| 290005302 | 290003868 | null | 179 | Palliative (P) | 2014-10-26 | 2014-11-09 | Capecitabine | N | N | 290022746 | LANREOTIDE |
| 290005303 | 290003869 | 1.66 | 79.8 | Neo-adjuvant (N) | 2017-12-12 | 2017-12-12 | Pazopanib | 2 | N | 290022748 | TRIAL |
| 290005304 | 290003870 | null | 179 | Adjuvant (A) | 2016-07-29 | 2016-08-12 | OCTREOTIDE | 02 | Y | 290022750 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 290005305 | 290003871 | null | 60.5 | Adjuvant (A) | 2017-08-20 | 2017-08-20 | INTERFERON | N | N | 290022751 | TRIAL |